Reviewing BeyondAirInc . (XAIR) & Its Rivals
BeyondAirInc . (NASDAQ: XAIR) is one of 127 public companies in the “Surgical & medical instruments” industry, but how does it compare to its peers? We will compare BeyondAirInc . to related companies based on the strength of its valuation, profitability, earnings, risk, institutional ownership, analyst recommendations and dividends.
Risk and Volatility
BeyondAirInc . has a beta of -0.25, indicating that its stock price is 125% less volatile than the S&P 500. Comparatively, BeyondAirInc .’s peers have a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.
This table compares BeyondAirInc . and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|BeyondAirInc .||$7.72 million||-$6.56 million||-5.83|
|BeyondAirInc . Competitors||$1.43 billion||$145.31 million||-12.03|
BeyondAirInc .’s peers have higher revenue and earnings than BeyondAirInc .. BeyondAirInc . is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
5.4% of BeyondAirInc . shares are owned by institutional investors. Comparatively, 51.4% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 15.4% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This table compares BeyondAirInc . and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|BeyondAirInc . Competitors||-674.05%||-624.80%||-22.23%|
This is a breakdown of current recommendations for BeyondAirInc . and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|BeyondAirInc . Competitors||950||3182||5391||284||2.51|
As a group, “Surgical & medical instruments” companies have a potential upside of 20.91%. Given BeyondAirInc .’s peers higher possible upside, analysts plainly believe BeyondAirInc . has less favorable growth aspects than its peers.
BeyondAirInc . peers beat BeyondAirInc . on 7 of the 10 factors compared.
About BeyondAirInc .
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.
Receive News & Ratings for BeyondAirInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondAirInc . and related companies with MarketBeat.com's FREE daily email newsletter.